{"id":"human-menopausal-gonadotropin","safety":{"commonSideEffects":[{"rate":"1-10%","effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":"5-15%","effect":"Headache"},{"rate":"10-20%","effect":"Abdominal pain or bloating"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-15%","effect":"Injection site reactions"},{"rate":"5%","effect":"Mood changes"}]},"_chembl":{"chemblId":"CHEMBL2108951","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"hMG is extracted from the urine of postmenopausal women and contains both FSH and LH in a 1:1 ratio. FSH directly stimulates follicle growth and estrogen production, while LH supports follicle maturation and triggers ovulation. This combination mimics the natural hormonal environment needed for controlled ovarian hyperstimulation in assisted reproductive technology.","oneSentence":"Human menopausal gonadotropin (hMG) is a hormone preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and maturation in women undergoing fertility treatment.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:23:16.108Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF)"},{"name":"Anovulation and ovulatory disorders in women seeking pregnancy"}]},"trialDetails":[{"nctId":"NCT03209687","phase":"PHASE4","title":"The Value of Addition of Human Menopausal Gonadotropin Drug Following Oocytes Retrieval in IVF Cycles","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-07-06","conditions":"Infertility","enrollment":600},{"nctId":"NCT07216742","phase":"PHASE3","title":"Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.","status":"RECRUITING","sponsor":"Granata Bio Corporation","startDate":"2025-11-01","conditions":"Infertility (IVF Patients)","enrollment":659},{"nctId":"NCT07340827","phase":"PHASE3","title":"A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)","status":"RECRUITING","sponsor":"Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany","startDate":"2026-02-05","conditions":"Infertility","enrollment":333},{"nctId":"NCT07043322","phase":"PHASE2","title":"Clinical Study to Evaluate Efficacy of Cabergoline to Coasting in Reducing the Incidence of Ovarian Hyperstimulation Syndrome","status":"RECRUITING","sponsor":"Tanta University","startDate":"2025-06-30","conditions":"Gynecologic Disease","enrollment":150},{"nctId":"NCT07457684","phase":"","title":"Comparison of Follitropin Delta and Follitropin Alfa in Combination With Menotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2025-12-05","conditions":"IVF Outcomes, OVARIAN STIMULATION","enrollment":846},{"nctId":"NCT05296798","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2022-07-18","conditions":"Locally Advanced or Metastatic Breast Cancer","enrollment":922},{"nctId":"NCT05847283","phase":"NA","title":"DPOS Versus GnRH Antagonist Protocol for Oocyte Accumulation in Low Ovarian Reserve Patients: An RCT","status":"RECRUITING","sponsor":"Tam Anh TP. Ho Chi Minh General Hospital","startDate":"2023-06-22","conditions":"Diminished Ovarian Reserve","enrollment":730},{"nctId":"NCT05873725","phase":"","title":"Retrospective Study of High Dose Follitropin Delta in a Mixed Protocol With Human Chorionic Gonadotropin","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2023-05-20","conditions":"IVF, Infertility","enrollment":118},{"nctId":"NCT04166825","phase":"NA","title":"Ovarian Hyperstimulation and Fibrin Clot Properties.","status":"RECRUITING","sponsor":"Jagiellonian University","startDate":"2019-11-18","conditions":"Fibrin Blood Clot, Infertility, Female, Endometriosis","enrollment":300},{"nctId":"NCT03822468","phase":"PHASE2","title":"Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-06-11","conditions":"Breast Cancer","enrollment":376},{"nctId":"NCT05870579","phase":"PHASE1","title":"[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer","status":"RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2023-11-13","conditions":"Breast Cancer","enrollment":48},{"nctId":"NCT06997900","phase":"PHASE2","title":"Menopur And Rekovelle Combination Study Version 2.0","status":"RECRUITING","sponsor":"Clinique Ovo","startDate":"2025-07-04","conditions":"IVF, Controlled Ovarian Simulation, Fertility Disorders","enrollment":200},{"nctId":"NCT06732843","phase":"","title":"Does Recombinant FSH (rFSH, i.g. Gonal F®) as Compared to Human Menopausal Gonadotrophin (hMG) Affect Telomere Length of Cumulus Cells During Antral Follicle Growth and Impact Blastocyst Status?","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-07-23","conditions":"OVARIAN STIMULATION, Telomere Length, Telomere Length, Mean Leukocyte","enrollment":10},{"nctId":"NCT07076719","phase":"","title":"Cell-free DNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for Preimplantation Genetic Diagnosis","status":"COMPLETED","sponsor":"Sohag University","startDate":"2023-10-01","conditions":"to Evaluate the Feasibility and Accuracy of Using cfDNA Analysis of Spent Embryo Culture Media as a Non-invasive Approach for PGD","enrollment":20},{"nctId":"NCT05815719","phase":"PHASE4","title":"Continuous Double Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2022-11-17","conditions":"Fertility Issues","enrollment":30},{"nctId":"NCT06966219","phase":"","title":"Trigger Protocol on the Rate of Pregnancy After Intracytoplasmic Sperm Injection","status":"ACTIVE_NOT_RECRUITING","sponsor":"Suez University","startDate":"2025-05-01","conditions":"Infertility","enrollment":90},{"nctId":"NCT01354834","phase":"","title":"Assessment of the Effectiveness of Menopur in Intrauterine Insemination","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2004-03","conditions":"Infertility","enrollment":207},{"nctId":"NCT03737253","phase":"NA","title":"Hormone Evaluation in Artificial Reproductive Technology","status":"COMPLETED","sponsor":"Lund University","startDate":"2016-09","conditions":"Female Infertility","enrollment":810},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT05103228","phase":"NA","title":"Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders","status":"COMPLETED","sponsor":"Peter Kovacs MD","startDate":"2021-12-02","conditions":"Infertility, Ovarian Dysfunction","enrollment":190},{"nctId":"NCT01921166","phase":"PHASE4","title":"Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2011-01","conditions":"Infertility","enrollment":23},{"nctId":"NCT06486870","phase":"PHASE3","title":"Comparison Between Two Ovulation Induction Therapies and LOD on Clinical Outcomes in CC-Resistant PCOS Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2020-01-01","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":183},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT03272477","phase":"PHASE2","title":"Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients","status":"COMPLETED","sponsor":"Palleos Healthcare GmbH","startDate":"2017-10-05","conditions":"Breast Neoplasms","enrollment":257},{"nctId":"NCT06297564","phase":"NA","title":"Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments","status":"COMPLETED","sponsor":"New Valley University","startDate":"2022-09-01","conditions":"Progesterone Primed Endometrial Protocol, Gonadotropin Releasing Hormone Antagonist Protocol, Assisted Reproductive Treatments","enrollment":40},{"nctId":"NCT04989348","phase":"NA","title":"Euploid Rate of Blastocyst Derived From PPOS VS Antagonist Protocol","status":"COMPLETED","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2021-08-04","conditions":"IVF","enrollment":240},{"nctId":"NCT05737979","phase":"","title":"Modified Rekovelle and Menopur Combination Protocol to Avoid Monitoring Before Day 10 of Stimulation","status":"COMPLETED","sponsor":"Clinique Ovo","startDate":"2023-01-27","conditions":"Infertility, IVF","enrollment":772},{"nctId":"NCT06199960","phase":"PHASE3","title":"Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2019-08-02","conditions":"Assisted Reproductive Techniques","enrollment":116},{"nctId":"NCT05567731","phase":"NA","title":"Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve","status":"COMPLETED","sponsor":"Tanta University","startDate":"2022-10-15","conditions":"Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility","enrollment":30},{"nctId":"NCT04163458","phase":"PHASE3","title":"Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2019-10-25","conditions":"Infertility","enrollment":405},{"nctId":"NCT02330757","phase":"PHASE4","title":"HRT Versus MOS for Endometrial Preparation Prior to FET in Non PCOS Patients","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2016-10-10","conditions":"Infertility","enrollment":150},{"nctId":"NCT04724486","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04724343","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT04727684","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSI","status":"COMPLETED","sponsor":"Damascus University","startDate":"2020-08-22","conditions":"In Vitro Fertilization, Infertility, Intracytoplasmic Sperm Injection","enrollment":50},{"nctId":"NCT04727671","phase":"PHASE4","title":"Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.","status":"COMPLETED","sponsor":"Damascus University","startDate":"2019-12-22","conditions":"In Vitro Fertilization, Intracytoplasmic Sperm Injection, Infertility","enrollment":50},{"nctId":"NCT06093984","phase":"NA","title":"Cumulative Live Birth Rates in Dual Ovarian Stimulation Versus Two Antagonist Stimulations in Poor Ovarian Responders","status":"NOT_YET_RECRUITING","sponsor":"Shanghai First Maternity and Infant Hospital","startDate":"2023-11-01","conditions":"Infertility","enrollment":260},{"nctId":"NCT02554279","phase":"PHASE4","title":"MENOPUR® in a Gonadotropin-Releasing Hormone (GnRH) Antagonist Cycle With Single-Blastocyst Transfer in a High Responder Subject Population","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2015-08-31","conditions":"Infertility","enrollment":620},{"nctId":"NCT06006091","phase":"NA","title":"The Effectiveness of the Letrozole-induced Endometrial Preparation Protocol in Frozen-thawed Embryo Transfer (FET)","status":"RECRUITING","sponsor":"International Peace Maternity and Child Health Hospital","startDate":"2023-08-01","conditions":"Letrozole, Infertility, Female","enrollment":858},{"nctId":"NCT04189133","phase":"PHASE2","title":"Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2022-01-19","conditions":"Acquired Hypogonadotropic Hypogonadism","enrollment":32},{"nctId":"NCT04157725","phase":"PHASE4","title":"Mild Stimulation Protocol Using Clomiphene Citrate for Women With PCOS Undergoing in Vitro Fertilization","status":"UNKNOWN","sponsor":"American University of Beirut Medical Center","startDate":"2023-06-01","conditions":"PCO - Polycystic Ovaries, Infertility","enrollment":154},{"nctId":"NCT05864937","phase":"","title":"C677T Methylenetetrahydrofolate Reductase Mutation","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2011-12-01","conditions":"Mutation","enrollment":363},{"nctId":"NCT02912988","phase":"PHASE3","title":"Letrozole in Stimulated IVF Cycles","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2018-03-01","conditions":"Subfertility","enrollment":900},{"nctId":"NCT04071574","phase":"PHASE1, PHASE2","title":"Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility","status":"COMPLETED","sponsor":"Lebanese University","startDate":"2018-02-01","conditions":"Female Infertility, Female Infertility Due to Ovulatory Disorder, Premature Ovarian Failure","enrollment":200},{"nctId":"NCT04168892","phase":"","title":"Anti-Müllerian Hormone (AMH) Measured With Fully Automated Assay Versus AFC in the Prediction of Ovarian Response","status":"COMPLETED","sponsor":"Andros Day Surgery Clinic","startDate":"2019-09-20","conditions":"Ovarian Response","enrollment":160},{"nctId":"NCT04814940","phase":"","title":"Retrospective Analysis of Real-world Data From Medical Records on the Use of MENOPUR for Infertility Treatment","status":"WITHDRAWN","sponsor":"Ferring Pharmaceuticals","startDate":"2022-09-01","conditions":"Infertility, Female","enrollment":""},{"nctId":"NCT01035099","phase":"PHASE4","title":"RCT of Fixed vs Titrated Letrozole in Breast Cancer Patient Undergoing IVF","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2009-11","conditions":"Breast Cancer, Infertility","enrollment":41},{"nctId":"NCT04193930","phase":"NA","title":"Different Protocols in Ovarian Stimulation in Intracytoplasmic Sperm Injection Cycles","status":"WITHDRAWN","sponsor":"Assiut University","startDate":"2021-01-01","conditions":"ART","enrollment":""},{"nctId":"NCT05370794","phase":"","title":"Is in Vitro Maturation of Oocytes Influenced by the Origin of Gonadotropins Used in Maturation Medium: is There a Difference in Efficiency When Using Urinary Versus Recombinant Produced Follicle Stimulating Hormone and Human Chorionic Gonadotropin","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2022-04-19","conditions":"In Vitro Maturation of Oocytes","enrollment":35},{"nctId":"NCT04902131","phase":"PHASE1","title":"A Study Comparing MENOPUR in a Pen Formulation With a Powder and Solvent Formulation in Healthy Women","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2021-11-02","conditions":"Infertility, Female","enrollment":95},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":"Infertility","enrollment":201},{"nctId":"NCT04537078","phase":"PHASE3","title":"Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor Responders","status":"COMPLETED","sponsor":"El Shatby University Hospital for Obstetrics and Gynecology","startDate":"2020-09-01","conditions":"Infertility, Female","enrollment":90},{"nctId":"NCT05220995","phase":"","title":"The Effects of Miminal Stimulation Protocol on Preimplantation Genetic Screening","status":"UNKNOWN","sponsor":"Gokalp Oner","startDate":"2021-05-15","conditions":"Preimplantation Genetic Screening","enrollment":200},{"nctId":"NCT04876300","phase":"","title":"MEDAM (Menopur Retrospective Data prograM)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2021-11-04","conditions":"Infertility, Female","enrollment":11488},{"nctId":"NCT03578172","phase":"NA","title":"HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients","status":"COMPLETED","sponsor":"Reproductive & Genetic Hospital of CITIC-Xiangya","startDate":"2018-07-18","conditions":"Infertility, Female, Intrauterine Adhesion","enrollment":186},{"nctId":"NCT05112692","phase":"NA","title":"Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI Cycles","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2021-11","conditions":"PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries","enrollment":200},{"nctId":"NCT04854707","phase":"","title":"An Observational Study of Follitropin Alpha Biosimilar: the Real-world Data","status":"COMPLETED","sponsor":"IVFarma LLC","startDate":"2020-01-12","conditions":"Reproductive Issues, Reproductive Disorder, Fertility Disorders","enrollment":5484},{"nctId":"NCT01354886","phase":"PHASE1","title":"Single Dose FSH-GEX™ in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-04","conditions":"Female Infertility","enrollment":19},{"nctId":"NCT01477073","phase":"PHASE1","title":"Multiple Dose FSH-GEX(TM) in Healthy Volunteers","status":"COMPLETED","sponsor":"Glycotope GmbH","startDate":"2011-10","conditions":"Female Infertility","enrollment":57},{"nctId":"NCT04870502","phase":"PHASE2, PHASE3","title":"Effect of Ubiquinol Supplementation on Ovulation Induction in Clomiphene Citrate Resistance","status":"COMPLETED","sponsor":"Saudi German Hospital - Madinah","startDate":"2019-04-01","conditions":"Polycystic Ovarian Syndrome","enrollment":161},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT04297553","phase":"NA","title":"Fresh Versus Freeze-only After CAPA IVM on PCOS Patients","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2020-03-06","conditions":"PCOS, IVM, Embryo Transfer","enrollment":40},{"nctId":"NCT03208972","phase":"PHASE4","title":"Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG","status":"COMPLETED","sponsor":"AZ Jan Palfijn Gent","startDate":"2014-10","conditions":"Infertility","enrollment":107},{"nctId":"NCT03291821","phase":"NA","title":"DuoStim in Cases of PGT: Comparison of Embryo Quantity and Embryonic Quality Using MitoScore","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2017-12-01","conditions":"Infertility, Female","enrollment":136},{"nctId":"NCT04610957","phase":"NA","title":"Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"FAlbasri","startDate":"2019-01-01","conditions":"Ovulation Induction, Polycystic Ovary Syndrome","enrollment":160},{"nctId":"NCT02418533","phase":"NA","title":"Mono-menotropins Versus rFSH Protocol on Embryo Quality","status":"COMPLETED","sponsor":"Main Line Fertility Center","startDate":"2015-03","conditions":"Infertility, Fertility","enrollment":109},{"nctId":"NCT04493788","phase":"","title":"Molecular Basis of PCOS in Oocytes and Surrounding Cells","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2020-07","conditions":"Polycystic Ovary Syndrome","enrollment":30},{"nctId":"NCT04458454","phase":"","title":"\"Study of the Effects of Serum and Follicular Fluid Relaxin Levels on Ovarian Function in IVF Cycles\"","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2019-12-02","conditions":"Infertility, Reproductive Techniques, Assisted, Oocyte Maturation","enrollment":11},{"nctId":"NCT04385342","phase":"PHASE4","title":"FSH Followed by HMG vs FSH Plus HMG in IVF","status":"UNKNOWN","sponsor":"Mansoura University","startDate":"2020-06-30","conditions":"IVF","enrollment":530},{"nctId":"NCT04416607","phase":"NA","title":"Corifollitropin Alpha and Ovarian Response","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2018-06-15","conditions":"Infertility, Female","enrollment":300},{"nctId":"NCT03178695","phase":"PHASE1","title":"Inovium Ovarian Rejuvenation Trials","status":"COMPLETED","sponsor":"Ascendance Biomedical","startDate":"2017-06-01","conditions":"Perimenopausal Disorder, Menopause, Menopause, Premature","enrollment":200},{"nctId":"NCT03687606","phase":"PHASE4","title":"Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2018-10-18","conditions":"Isolated Hypogonadotropic Hypogonadism, Kallmann Syndrome, Infertility","enrollment":210},{"nctId":"NCT02179255","phase":"PHASE1, PHASE2","title":"Human Growth Hormone Pre-treatment for 6 Weeks Prior to Ovulation Induction for IVF","status":"UNKNOWN","sponsor":"Center for Human Reproduction","startDate":"2014-08-01","conditions":"Female Infertility Due to Diminished Ovarian Reserve","enrollment":30},{"nctId":"NCT03405701","phase":"NA","title":"IVM Versus IVF in High Antral Follicle Count Patients","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2018-01-25","conditions":"PCOS, IVF, IVM","enrollment":546},{"nctId":"NCT04175990","phase":"PHASE1","title":"IVF Outcome Following Progestogen Ovarian Stimulation","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2018-05-10","conditions":"IVF, Oocyte Maturation Defect 1, Clinical Pregnancy Rate","enrollment":155},{"nctId":"NCT01969201","phase":"PHASE4","title":"FSH in GnRH-AntagoniST Controlled Ovarian Hyperstimulation Cycles (FAST)","status":"COMPLETED","sponsor":"IBSA Institut Biochimique SA","startDate":"2014-01","conditions":"Infertility","enrollment":710},{"nctId":"NCT02896023","phase":"PHASE4","title":"Predictors of Ovarian Reserve in Infertile Women","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-09","conditions":"Ovarian Reserve","enrollment":100},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT03483545","phase":"NA","title":"Menopur And Rekovelle Combination Study","status":"COMPLETED","sponsor":"Dr François Bissonnette","startDate":"2018-07-17","conditions":"Fertility Disorders","enrollment":160},{"nctId":"NCT02835469","phase":"","title":"A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-06","conditions":"Infertility","enrollment":412},{"nctId":"NCT02865681","phase":"NA","title":"Protocol to Minimize Injections and Blood Draws for Women Undergoing in Vitro Fertilization","status":"COMPLETED","sponsor":"New Hope Fertility Center","startDate":"2016-07-01","conditions":"Infertility","enrollment":4},{"nctId":"NCT01551368","phase":"PHASE2","title":"Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2012-12","conditions":"Infertility","enrollment":12},{"nctId":"NCT02935335","phase":"","title":"A Study to Measure Relationship Between Antimüllerian Hormone and Initial Dose of Menopur®","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2016-10","conditions":"Infertility","enrollment":297},{"nctId":"NCT03825445","phase":"NA","title":"GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.","status":"COMPLETED","sponsor":"Hue University of Medicine and Pharmacy","startDate":"2016-04-01","conditions":"Ovulation Induction","enrollment":197},{"nctId":"NCT03784404","phase":"PHASE4","title":"Trans-vaginal Aspiration of Small Ovarian Endometrioma. Comparison of Two Different Techniques Before ICSI","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-12","conditions":"Ovarian Endometrioma","enrollment":100},{"nctId":"NCT02273791","phase":"","title":"HRT Versus MOS for Endometrial Preparation Prior to FET in PCOS Patients","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2013-12","conditions":"Infertility, Polycystic Ovarian Syndrome","enrollment":126},{"nctId":"NCT03684824","phase":"NA","title":"Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2018-09","conditions":"Invitro Fertilization","enrollment":100},{"nctId":"NCT01882166","phase":"NA","title":"Time-lapse Monitoring of Early Embryo Development After Ovarian Stimulation During Infertility Treatment","status":"TERMINATED","sponsor":"St. Olavs Hospital","startDate":"2013-10","conditions":"Infertility, Female","enrollment":20},{"nctId":"NCT02625519","phase":"PHASE4","title":"Efficacy of Urinary Vs Recombinant FSH in Oocyte Donors Based on Receptor N680S FSH Gene Polymorphism (Genodon Trial)","status":"UNKNOWN","sponsor":"Instituto Bernabeu","startDate":"2015-12","conditions":"Reproductive Techniques, Assisted","enrollment":180},{"nctId":"NCT02737800","phase":"NA","title":"Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients","status":"COMPLETED","sponsor":"Kasr El Aini Hospital","startDate":"2016-04","conditions":"Endometrioma","enrollment":88},{"nctId":"NCT03402620","phase":"NA","title":"Poor Responders Infertile Patients -A Great Clinical Challenge","status":"COMPLETED","sponsor":"Cairo University","startDate":"2018-01-11","conditions":"Invitro Fertilization","enrollment":102},{"nctId":"NCT02431689","phase":"NA","title":"Delayed Embryo Transfer in Poor Responders","status":"COMPLETED","sponsor":"Cairo University","startDate":"2015-04","conditions":"Infertility","enrollment":400},{"nctId":"NCT03098199","phase":"NA","title":"AMH and Dosing Regimens for Initial IVF Stimulation Protocols","status":"COMPLETED","sponsor":"Reproductive Specialists of New York","startDate":"2015-10-22","conditions":"Infertility","enrollment":78},{"nctId":"NCT03484611","phase":"NA","title":"Prediction of Metaphase II Oocytes According to Different Levels of Serum AMH in Poor Responders Using the Antagonist Protocol","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2013-01","conditions":"Invitro Fertilizaion","enrollment":179},{"nctId":"NCT03480412","phase":"","title":"Second Step Protocol in Poor Ovarian Responder (POR)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-09-01","conditions":"Infertility, Female, Premature Ovarian Failure, Fertility Disorders","enrollment":50},{"nctId":"NCT02069808","phase":"PHASE4","title":"Efficacy of Recombinant FSH/GnRH Antagonist Protocol With and Without LH Adjunct for Egg Bank Donation","status":"COMPLETED","sponsor":"Michigan Reproductive Medicine","startDate":"2014-04","conditions":"Egg Donation","enrollment":38},{"nctId":"NCT03457233","phase":"NA","title":"The Impact of Body Weight on Reproductive Outcomes in Poor Ovarian Responders in ICSI Cycles","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-01-03","conditions":"Invitro Fertilization","enrollment":185},{"nctId":"NCT02605070","phase":"PHASE3","title":"Pilot Study on the Effects of FSH Treatment on the Epigenetic Characteristics of Spermatozoa in Infertile Patients With Severe Oligozoospermia","status":"TERMINATED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2015-11","conditions":"Male Infertility","enrollment":30},{"nctId":"NCT02381821","phase":"","title":"Endometrial Volume and Sub-endometrial Vascularity as Predictors of In-vitro Fertilization Success","status":"COMPLETED","sponsor":"Cairo University","startDate":"2016-01-01","conditions":"Reproductive Techniques, Assisted","enrollment":82},{"nctId":"NCT02469805","phase":"PHASE3","title":"Stimulated Versus Un-stimulated Intrauterine Insemination Cycles in Couples With Mild Male Factor Infertility","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2015-06","conditions":"Subfertility","enrollment":450},{"nctId":"NCT02338206","phase":"PHASE2","title":"Long Protocol and Growth Hormone in Poor Responders","status":"COMPLETED","sponsor":"Woman's Health University Hospital, Egypt","startDate":"2015-03","conditions":"Infertility","enrollment":240}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["menopur","meriofert","Merional","Human Menopausal Gonadotropin(hMG)","hMG"],"phase":"marketed","status":"active","brandName":"human menopausal gonadotropin","genericName":"human menopausal gonadotropin","companyName":"IVI Madrid","companyId":"ivi-madrid","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Human menopausal gonadotropin (hMG) is a hormone preparation containing follicle-stimulating hormone (FSH) and luteinizing hormone (LH) that stimulates ovarian follicle development and maturation in women undergoing fertility treatment. Used for Infertility in women undergoing assisted reproductive technology (ART) / in vitro fertilization (IVF), Anovulation and ovulatory disorders in women seeking pregnancy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":4,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}